Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.

Leukemia 2004 Apr;18(4):734-42

The Center for Human Genetics, University Hospital Leuven, Leuven, Belgium.

Detection of the FIP1L1-PDGFRA fusion gene or the corresponding cryptic 4q12 deletion supports the diagnosis of chronic eosinophilic leukemia (CEL) in patients with chronic hypereosinophilia. We retrospectively characterized 17 patients fulfilling WHO criteria for idiopathic hypereosinophilic syndrome (IHES) or CEL, using nested RT-PCR and interphase fluorescence in situ hybridization (FISH). Eight had FIP1L1-PDGFRA (+) CEL, three had FIP1L1-PDGFRA (-) CEL and six had IHES. FIP1L1-PDGFRA (+) CEL responded poorly to steroids, hydroxyurea or interferon-alpha, and had a high probability of eosinophilic endomyocarditis (n=4) and disease-related death (n=4). In FIP1L1-PDGFRA (+) CEL, palpable splenomegaly was present in 5/8 cases, serum vitamin B(12) was always markedly increased, and marrow biopsies revealed a distinctively myeloproliferative aspect. Imatinib induced rapid complete hematological responses in 4/4 treated FIP1L1-PDGFRA (+) cases, including one female, and complete molecular remission in 2/3 evaluable cases. In the female patient, 1 log reduction of FIP1L1-PDGFRA copy number was reached as by real-time quantitative PCR (RQ-PCR). Thus, correlating IHES/CEL genotype with phenotype, FIP1L1-PDGFRA (+) CEL emerges as a homogeneous clinicobiological entity, where imatinib can induce molecular remission. While RT-PCR and interphase FISH are equally valid diagnostic tools, the role of marrow biopsy in diagnosis and of RQ-PCR in disease and therapy monitoring needs further evaluation.

Download full-text PDF

Source
http://www.nature.com/articles/2403313
Publisher Site
http://dx.doi.org/10.1038/sj.leu.2403313DOI Listing
April 2004
8 Reads

Publication Analysis

Top Keywords

fip1l1-pdgfra cel
20
molecular remission
8
chronic eosinophilic
8
rt-pcr interphase
8
fip1l1-pdgfra
8
cel
7
splenomegaly 5/8
4
cel emerges
4
death n=4
4
n=4 fip1l1-pdgfra
4
cel palpable
4
palpable splenomegaly
4
cases serum
4
ihes/cel genotype
4
b12 markedly
4
markedly increased
4
vitamin b12
4
serum vitamin
4
phenotype fip1l1-pdgfra
4
disease-related death
4

References

(Supplied by CrossRef)

BJ Bain et al.
Br J Haematol 1996

BJ Bain et al.
Curr Opin Hematol 2000

MJ Chusid et al.
Medicine (Baltimore) 1975

B Bain et al.
2001

J Zittoun et al.
Blood 1984

AS Fauci et al.
Ann Intern Med 1982

P Weller et al.
Blood 1994

J Cools et al.
N Engl J Med 2003

J Cools et al.
Cancer Cell 2003

GJ Gleich et al.
Lancet 2002

A Pardanani et al.
Blood 2003

Similar Publications